Marinomed Granted Chinese Patent for Antiviral Polymer

21-Nov-2012 - Austria

Marinomed Biotechnologie GmbH announced that it has been granted Chinese Patent No. CN101678040, entitled ‘Antiviral polymer’, by the Chinese patent office. The patent covers the use of a specific polymer for the prevention and treatment of rhinovirus infections.

Dr. Andreas Grassauer, CEO and co-founder of Marinomed, commented: “The national granting of this patent is an important further step in protecting Marinomed’s intellectual property and know-how around our anti-viral product portfolio based on our mavirex technology platform. Furthermore this patent contributes value in the out-licensing of our products or technology to partner companies in China.”

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances